Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
$DCGO (-26.8% pre) DocGo Inc. Reports Mixed 2024 Financial Results https://t.co/v4gI8wkxM9
$TDOC. $9.80 -10% Phew, I i thought I'd misinterpreted management tone at the JPM meeting in January, but here we are. I read the ER transcript, seems like a bit of a grey mishmash. Even BetterHelp doesn't seem to be coming right in good time, & I'm not convinced fiddling with… https://t.co/ob1B1ekLwj
$TDOC (-12.2% pre) Teladoc shares tumble on wider-than-expected loss, disappointing revenue guidance https://t.co/spXwbyuAeG
Teladoc Health Inc. reported a wider-than-expected loss, leading to a significant drop in its share price. The company's shares fell by 12.2% in pre-market trading, with the stock priced at approximately $9.80. Analysts have noted that the company's revenue guidance was disappointing, raising concerns about its cost structure and growth potential. The enterprise value of Teladoc is estimated to be under $2 billion, with projected revenues of $2.5 billion and EBITDA of $300 billion for 2025. Additionally, DocGo Inc. experienced a pre-market decline of 26.8% after reporting mixed financial results for 2024.